- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT06756646
Exploring the Effects of Aerobic Exercise Combined With BFRT on Patients With COPD
Exploring the Effects of Aerobic Exercise Combined With Blood Flow Restriction Training on Exercise Capacity, Cardiopulmonary Functions, and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease
Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in COPD patients.
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
The systemic effects of Chronic Obstructive Pulmonary Disease (COPD) can precipitate a series of complications, including cardiovascular disorders, muscle atrophy, and osteoporosis. These comorbid conditions often result in decreased physical activity and suboptimal physical fitness, compelling patients to lead a sedentary lifestyle to mitigate exercise-induced dyspnea. Addressing the limitations in exercise tolerance remains a critical therapeutic goal in the treatment of COPD. According to research, exercise intolerance is caused by both poor pulmonary function and associated skeletal muscle dysfunction. Blood flow restriction training, a new rehabilitation technique, has shown promise in improving muscular strength at lower exercise intensities and in shorter timeframes, presenting a fresh approach to COPD rehabilitation.
The research aims to investigate the impact of incorporating blood flow restriction training into a holistic aerobic exercise program on exercise capacity and quality of life among patients with COPD. The findings are intended to clarify the potential of this innovative training technique as a supplementary therapeutic strategy in the management of COPD.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Kun-Ling Tsai, Ph.D.
- Telefonnummer: 5078 886-6-2353535
- E-Mail: kunlingtsai@mail.ncku.edu.tw
Studieren Sie die Kontaktsicherung
- Name: Yu-Ting Huang, M.S.
- Telefonnummer: 5078 886-6-2353535
- E-Mail: t66061053@pt.ncku.edu.tw
Studienorte
-
-
Taiwan
-
Tainan, Taiwan, Taiwan, 701
- Rekrutierung
- National Cheng Kung University Hostipal
-
Kontakt:
- Kun-Ling Tsai, PhD
- Telefonnummer: 6219 062353535
- E-Mail: kunlingtsai@mail.ncku.edu.tw
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- COPD classified as levels 2-4.
- Stable condition without worsening in the past three months.
- No participation in any rehabilitation program within the past six months.
- Ability to understand and follow verbal commands and cooperate with an exercise training program.
Exclusion Criteria:
- Unconscious or unable to cooperate with the evaluator.
- Hospitalization due to acute illness within the past three months.
- Severe joint diseases or history of lower limb surgery.
- Severe cardiovascular disease (e.g., presence of a cardiac pacemaker or acute myocardial infarction within the past six months).
- Dependence on oxygen supply.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Usual care group
The Usual care group will receive COPD and exercise-related education. |
The participants will be provided by educational program about COPD self-care and home-based exercise approach. |
|
Experimental: Aerobic exercise group-cycling
The aerobic exercise group will receive cycling training intervention 2-3 times per week for 2 months. |
The aerobic exercise intervention will utilize an ergometer. The program will be conducted 2-3 times per week over a 3-month period. |
|
Experimental: BFR group-cycling + BFR
The BFR group will receive cycling training combined with BFR intervention 2-3 times per week for 2 months. |
Blood flow restriction (BFR) intervention will combine aerobic exercise on the ergometer with BFR training. The program will be conducted 2-3 times per week over a 3-month period. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Oxygen consumption (VO2)
Zeitfenster: Change from baseline (0 week) to follow up (20 weeks)
|
Oxygen consumption examined by cardiopulmonary exercise test |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Functional capacity
Zeitfenster: Change from baseline (0 week) to follow up (20 weeks)
|
Functional capacity examined by 6MWT |
Change from baseline (0 week) to follow up (20 weeks)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Heart Rate Variability
Zeitfenster: Change from baseline (0 week) to follow up (20 weeks)
|
Heart Rate Variability examined by autonomic nervous system |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Pulmonary function test
Zeitfenster: Change from baseline (0 week) to follow up (20 weeks)
|
Pulmonary function test examined by spirometer. Spirometry is a physiological test that measures the ability to inhale and exhale air over time. The main spirometry results are forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and the FEV1/FVC ratio. |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Maximum respiratory pressure
Zeitfenster: Change from baseline (0 week) to follow up (20 weeks)
|
Maximum respiratory pressure examined by pressure meter |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-I)
Zeitfenster: Change from baseline (0 week) to follow up (20 weeks)
|
Quality of life score examined by mMRC Questionnaire. |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-II)
Zeitfenster: Change from baseline (0 week) to follow up (20 weeks)
|
COPD Assessment Test (CAT) questionaire |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-III)
Zeitfenster: Change from baseline (0 week) to follow up (20 weeks)
|
St George's Respiratory Questionnaire (SGRQ) |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Diaphragm capacity
Zeitfenster: Change from baseline (0 week) to follow up (20 weeks)
|
Diaphragm capacity examined by diaphragmatic ultrasound |
Change from baseline (0 week) to follow up (20 weeks)
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Kun-Ling Tsai, Ph.D., Department of Physical Therapy, National Cheng Kung University
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- B-ER-113-298
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
IPD sharing plan will be decided after summarized data being published.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .